01774-X/asset/3608bfb3-6329-4132-95b7-cc3434437493/main.assets/gr2_lrg.jpg)
tirzepatide pediatric Efficacy and safety of in children and adolescents with type 2 diabetes (SURPASS-PEDS): a randomised, double-blind, placebo-controlled, phase 3 trial New Pricing, Access to Tirzepatide
Description
Distinguishing whether pancreatitis cases result from the medication, underlying metabolic conditions, or other factors remains challenging
This cost barrier is the single biggest reason they are not more widely used
Results should be interpreted with a qualified healthcare provider
At 20 mg/mL, the same 60 units delivers 12 mg, which is a high dose near the maximum
For most people, a healthy calorie deficit is around 300500 calories per day
Coverage for weight loss medications like Zepbound or Wegovy largely depends on your specific insurance plan and typically requires prior authorization
